What Is the First-Line Treatment for Granuloma faciale?
Granuloma faciale is a chronic benign dermatosis of the face. Published evidence supports a clear starting point for management, centred on topical therapy as the first-choice approach.
Treatment Approach
Topical therapy is recommended as the first line of treatment. Among the available topical agents, a specific calcineurin inhibitor has shown the strongest results across reported case series, with additional topical options potentially incorporated depending on response.
References
DOI: 10.2340/00015555-2784
- Topical glucocorticosteroids and tacrolimus remain treatments of first choice, possibly supplemented by topical dapsone.
- Tacrolimus 0.1% ointment applied twice daily seems to be the most valuable treatment option, all 28 reported patients benefitted from this topical treatment, and 19 showed excellent results.
- Based on published treatment successes experienced in a minimum of more than 5 patients (Fig. 1), we suggest starting the treatment topically.
- Tacrolimus 0.1% ointment applied twice daily seems to be the most successful option.
- A trial with local dapsone gel is a further option that needs to be evaluated.
View source ↗